Oridonin is a naturally occurring diterpenoid isolated primarily from Isodon rubescens, a plant traditionally known in China as Dong Ling Cao. It has attracted substantial scientific interest because of its distinctive ent-kaurane-type molecular framework, diverse natural-product chemistry, and extensive research across molecular biology, pharmacology, pharmaceutical chemistry, and drug-discovery research.
For manufacturers and research organizations, however, understanding Oridonin requires more than reviewing its reported biological activities. The quality of a commercial Oridonin material depends on its botanical source, extraction and purification process, analytical methodology, purity specification, batch consistency, and supporting technical documentation.
This guide provides a research-oriented overview of Oridonin, with particular attention to high-purity 98% Oridonin, including its chemical identity, natural source, physicochemical characteristics, production considerations, analytical quality control, research applications, and practical supplier evaluation.
Oridonin is a naturally occurring ent-kaurane-type diterpenoid primarily associated with Isodon rubescens, a member of the Lamiaceae family. Its CAS number is 28957-04-2, molecular formula is C20H28O6, and molecular weight is approximately 364.4 g/mol.
Oridonin is one of the most extensively studied diterpenoids found in Isodon rubescens. Modern research has investigated its molecular interactions, cellular pathways, pharmacokinetic characteristics, structural modifications, and potential applications in natural-product and pharmaceutical research.
From a commercial perspective, high-purity Oridonin is different from a conventional Isodon rubescens or Dong Ling Cao extract. A standardized botanical extract contains multiple naturally occurring constituents, whereas 98% Oridonin is a purified single compound with a defined molecular identity and a much narrower analytical specification.
This distinction makes high-purity Oridonin particularly relevant to laboratories and manufacturers that require reproducible research materials, defined chemical composition, and quantitative analytical control.
For buyers, evaluating Oridonin quality should therefore go beyond the stated purity. Important considerations include HPLC methodology, chromatographic profile, identity confirmation, residual solvents, heavy metals, moisture, storage conditions, batch consistency, and the supplier's ability to provide complete technical documentation.
Oridonin is a naturally occurring diterpenoid primarily associated with Isodon rubescens.
CAS 28957-04-2 is the commonly recognized CAS identifier for Oridonin.
Its molecular formula is C20H28O6, with a molecular weight of approximately 364.4 g/mol.
Kew's Plants of the World Online currently accepts Isodon rubescens as the species name, while Rabdosia rubescens is treated as a synonym.
Oridonin belongs to the ent-kaurane diterpenoid family.
Isodon rubescens contains numerous diterpenoids and other secondary metabolites, with Oridonin among its best-studied constituents.
High-purity Oridonin and Isodon rubescens extract are not interchangeable products.
HPLC is an important analytical tool for evaluating Oridonin purity and the quality of Isodon rubescens-derived materials.
Research on Oridonin includes natural-product chemistry, molecular mechanisms, pharmacokinetics, structural modification, and drug-discovery studies.
Its relatively limited aqueous solubility and bioavailability remain important considerations in pharmaceutical research.
For B2B procurement, purity should be evaluated together with identity, analytical methodology, documentation, and batch consistency.
What Is Oridonin?
Why Is Oridonin Scientifically Important?
Oridonin Chemical Structure and Properties
Natural Source: Isodon rubescens
Oridonin vs. Isodon rubescens Extract
How Is High-Purity Oridonin Produced?
Oridonin Quality Standards and HPLC Analysis
Oridonin Solubility and Stability Considerations
Research Applications of Oridonin
Oridonin Derivatives and Structural Modification
How to Choose a Reliable Oridonin Supplier
Buyer Checklist for Oridonin 98%
Frequently Asked Questions
CQHERB Technical Insight
Scientific References
Oridonin is a naturally occurring diterpenoid found primarily in Isodon rubescens. It belongs to a structurally diverse family of plant-derived diterpenes and is characterized as an ent-kaurane-type diterpenoid.
The compound has been extensively investigated because of its distinctive polycyclic molecular framework and multiple oxygen-containing functional groups. These structural characteristics make Oridonin an important subject in natural-product chemistry and medicinal chemistry research.
The accepted botanical name is currently Isodon rubescens (Hemsl.) H.Hara, according to the Royal Botanic Gardens, Kew. Rabdosia rubescens is treated by Kew as a synonym. Both names therefore appear frequently in scientific publications and commercial literature.
Oridonin is a naturally occurring ent-kaurane diterpenoid with the molecular formula C20H28O6 and CAS 28957-04-2, primarily isolated from Isodon rubescens.
Oridonin has attracted sustained scientific attention for several reasons.
First, it represents a structurally distinctive natural-product scaffold. Second, it can be isolated and purified as a chemically defined compound, allowing researchers to investigate its molecular properties independently of the many other constituents found in the plant.
Third, a substantial body of research has investigated Oridonin in cellular, biochemical, pharmacokinetic, and medicinal-chemistry contexts. Reviews published in recent years have summarized research involving signaling pathways, cell-cycle regulation, apoptosis, autophagy, oxidative processes, and other molecular phenomena.
Importantly, much of this literature concerns preclinical or experimental research. Findings from cell models or animal studies should not automatically be interpreted as evidence of established clinical efficacy in humans.
This distinction is particularly important when presenting Oridonin on a commercial website.
Research reproducibility is strongly influenced by material consistency.
A crude botanical extract can contain numerous compounds whose concentrations vary according to:
Plant origin
Cultivar or genetic background
Growing conditions
Harvesting period
Extraction method
Processing conditions
Storage
A purified Oridonin material reduces many of these variables by providing a defined target compound.
For laboratory and formulation-development work, high-purity Oridonin can therefore offer:
Defined chemical identity
Standardized purity
Better batch-to-batch consistency
More reproducible analytical results
Easier comparison between experiments
More precise formulation calculations
|
Research Stage |
General Development |
|
Early natural-product research |
Isolation and structural characterization of Oridonin |
|
Later phytochemical research |
Expansion of research on Isodon diterpenoids |
|
Modern analytical research |
Improved HPLC and LC-MS characterization |
|
Molecular research era |
Increasing investigation of cellular and signaling mechanisms |
|
Recent research |
Structural modification, delivery systems, pharmacokinetics, and drug-discovery studies |
The continuing development of analytical and biochemical technologies has allowed researchers to investigate Oridonin at increasingly detailed molecular levels.
Oridonin is scientifically important not simply because it originates from a traditional medicinal plant, but because it combines a distinctive natural-product structure with extensive experimental research and the ability to be isolated as a defined compound.
|
Property |
Information |
|
Common Name |
Oridonin |
|
CAS Number |
28957-04-2 |
|
Molecular Formula |
C20H28O6 |
|
Molecular Weight |
364.4 g/mol |
|
Chemical Class |
ent-Kaurane diterpenoid |
|
Natural Source |
Isodon rubescens |
|
Typical High-Purity Specification |
≥98% by HPLC |
The molecular identity and basic chemical information are consistent with the PubChem record for Oridonin.
Oridonin possesses a complex tetracyclic diterpenoid framework containing several oxygenated functional groups and an enone-related structural motif.
This combination of structural features contributes to the compound's importance in medicinal-chemistry research.
Researchers have also used the Oridonin scaffold as a starting point for chemical modification. Various derivatives have been investigated with the goal of modifying properties such as solubility, stability, pharmacokinetics, and biological activity.
Diterpenoid
A natural product generally derived from four isoprene units and containing 20 carbon atoms.
ent-Kaurane diterpenoid
A structural class of diterpenoids characterized by a specific tetracyclic carbon skeleton.
HPLC
High-Performance Liquid Chromatography, an analytical technique commonly used to separate, identify, and quantify components in a sample.
Purity
The proportion of the target compound relative to other detectable components under a defined analytical method.
Oridonin's defined molecular formula and distinctive ent-kaurane diterpenoid structure make it suitable for detailed analytical and medicinal-chemistry research. Its structural framework has also become a useful starting point for investigating chemically modified derivatives.
The principal natural source associated with Oridonin is Isodon rubescens (Hemsl.) H.Hara, a species in the Lamiaceae family. Kew currently recognizes Isodon rubescens as the accepted name and lists Rabdosia rubescens as a synonym.
The species is native to central and southern China.
The plant is commonly known in Chinese contexts as Dong Ling Cao (冬凌草), and the dried aerial parts have a long history of use in traditional Chinese medicine.
One important point for buyers is that Isodon rubescens is not an Oridonin-only plant.
Scientific reviews have documented a large number of secondary metabolites from the species, including:
Diterpenoids
Triterpenoids
Phenolic compounds
Alkaloids
Volatile constituents
Other specialized metabolites
Among these constituents, diterpenoids represent one of the most extensively studied groups, with Oridonin being one of the best-known compounds.
The concentration of individual compounds in a botanical raw material can vary according to:
Plant genetics
Geographic origin
Cultivation conditions
Harvest time
Plant part
Drying conditions
Extraction technology
Research on Rabdosia rubescens has also demonstrated that the contents of several compounds can vary among different cultivars, reinforcing the importance of analytical quality control.
Isodon rubescens is the principal botanical source associated with Oridonin. Because the plant contains a complex mixture of diterpenoids and other secondary metabolites, high-purity Oridonin requires dedicated extraction and purification rather than simple botanical extraction.
This distinction is particularly important for international buyers.
|
Feature |
Oridonin 98% |
Isodon rubescens Extract |
|
Product Type |
Purified single compound |
Multi-component botanical extract |
|
Main Target |
Oridonin |
Multiple plant constituents |
|
Purity Specification |
Typically expressed as Oridonin % by HPLC |
May use extract ratio or marker-compound specification |
|
Chemical Composition |
Narrowly defined |
Complex |
|
Research Reproducibility |
High when analytical method is controlled |
Dependent on extract specification |
|
Typical Use |
Research, analytical and formulation development |
Botanical ingredient research and formulation |
|
Quality Control |
HPLC, identity, impurities and other specifications |
Marker compounds, extraction ratio, contaminants and other specifications |
If a project requires a defined concentration of Oridonin, purchasing a standardized high-purity Oridonin material is generally more straightforward than relying on a conventional Isodon rubescens extract.
If the project specifically requires the broader phytochemical profile of the plant, a standardized botanical extract may be more appropriate.
Oridonin 98% and Isodon rubescens extract should not be treated as equivalent products. The former is a purified compound; the latter is a complex botanical preparation with multiple constituents.
The production of high-purity Oridonin requires several stages because the target compound occurs together with numerous other constituents in the plant.
A simplified production concept is:
Botanical Raw Material
↓
Extraction
↓
Filtration / Concentration
↓
Fractionation
↓
Purification
↓
Crystallization or Further Refinement
↓
Drying
↓
HPLC Testing
↓
High-Purity Oridonin
The exact process depends on the manufacturer's technology, raw material specification, target purity, scale, and analytical requirements.
The first objective is to transfer Oridonin and related constituents from the plant matrix into an appropriate extract.
Extraction parameters may influence:
Yield
Impurity profile
Solvent consumption
Downstream purification requirements
Crude extracts contain many naturally occurring compounds.
Therefore, achieving a high Oridonin specification requires selective separation from:
Other diterpenoids
Pigments
Phenolic constituents
Lipophilic components
Other plant-derived impurities
Published research has demonstrated the use of chromatographic technologies such as high-speed counter-current chromatography for the isolation and purification of Oridonin from Isodon rubescens.
Following purification, analytical testing is used to determine whether the material meets the required specification.
HPLC can provide information about:
Retention time
Target peak
Relative purity
Chromatographic profile
Potential impurities
Research has also developed HPLC-based methods for simultaneous characterization and quantification of multiple compounds in Rabdosia rubescens, highlighting the importance of chromatographic analysis in quality control.
For high-purity botanical monomers, the manufacturing challenge is not simply "extracting more compound." The key challenge is achieving selective purification while maintaining reproducible analytical quality.
This is why a professional supplier should be able to explain not only the final purity but also the analytical method used to verify that specification.
Not necessarily.
A 98% purity statement is useful, but it should be interpreted together with the analytical method and supporting documentation.
When evaluating an Oridonin 98% material, buyers should review:
Confirm how the 98% value was determined.
Questions may include:
Which HPLC method was used?
Is the method clearly described?
Is the chromatogram available?
Is the purity calculated by area normalization or another method?
The supplier should be able to demonstrate that the tested compound is Oridonin rather than another diterpenoid with a similar chromatographic behavior.
A chromatogram can provide useful information about:
Main peak
Retention time
Secondary peaks
Overall sample profile
If organic solvents are used during manufacturing, residual solvent testing may be appropriate depending on the intended application and applicable standards.
For botanical-derived materials, buyers may also request information concerning:
Lead
Cadmium
Arsenic
Mercury
Microbiological parameters
For international B2B procurement, a professional supplier should be prepared to provide, where applicable:
Certificate of Analysis (COA)
Product Specification
HPLC Chromatogram
SDS / MSDS
Technical Data Sheet
Residual Solvent Information
Heavy Metal Information
Packaging Information
Storage Recommendations
Solubility is an important technical issue when working with Oridonin.
Published research has identified relatively limited aqueous solubility and bioavailability as important challenges in the development of Oridonin-based pharmaceutical formulations. Researchers have investigated approaches including structural modification, formulation technologies, nanoparticles, liposomes, and co-crystals to address these limitations.
For research and formulation developers, this means that Oridonin should not be evaluated only according to chemical purity.
Practical considerations can include:
Solvent selection
Concentration
Temperature
Storage conditions
Light exposure
Container compatibility
Formulation matrix
Two samples with identical HPLC purity can behave differently in a practical formulation if:
Particle size differs
Sample preparation differs
Solvent systems differ
Storage history differs
Experimental temperature differs
Therefore, research protocols should clearly document sample preparation conditions when Oridonin is used in solution-based experiments.
Oridonin's physicochemical characteristics, particularly its limited aqueous solubility, are important considerations for research and formulation development. High chemical purity does not automatically guarantee easy formulation or high bioavailability.
Oridonin has been investigated across several areas of scientific research.
Researchers study Oridonin as a representative ent-kaurane diterpenoid and as one component of the complex phytochemistry of Isodon rubescens.
Research topics include:
Isolation
Structural elucidation
Derivatization
Analytical characterization
Natural-product biosynthesis
A large body of experimental literature has examined Oridonin in relation to cellular processes such as:
Apoptosis
Autophagy
Cell-cycle regulation
Oxidative stress
Inflammatory signaling
Cellular metabolism
These findings are predominantly based on laboratory and preclinical models and should not be interpreted as proof of clinical efficacy.
Recent reviews continue to examine Oridonin's proposed molecular mechanisms and its interaction with multiple signaling pathways.
Oridonin has also become a useful starting scaffold for medicinal-chemistry research.
Researchers have explored structural modifications designed to address challenges such as:
Poor aqueous solubility
Limited bioavailability
Rapid clearance
Pharmacokinetic limitations
Oridonin derivatives have therefore become a separate research area within natural-product drug discovery.
Because Oridonin is a defined chemical compound, it can also be used in:
HPLC method development
LC-MS analysis
Reference-material research
Botanical quality-control studies
Comparative phytochemical analysis
The biological activities described in scientific literature do not mean that Oridonin 98% sold as a research ingredient is an approved pharmaceutical or that it is intended to diagnose, treat, cure, or prevent disease.
Research findings should always be interpreted according to the experimental model, concentration, formulation, and study design.
One particularly interesting aspect of Oridonin research is the development of chemically modified derivatives.
The natural Oridonin scaffold has been used as a starting point for exploring changes to functional groups and molecular regions that may affect:
Solubility
Stability
Target interaction
Pharmacokinetics
Biological activity
Reviews of Oridonin derivatives have documented extensive medicinal-chemistry research aimed at improving properties of the parent compound.
This research demonstrates an important principle in natural-product chemistry:
A natural compound can serve not only as a research material itself, but also as a structural template for the development of new chemical entities.
Oridonin continues to attract interest as both a natural compound and a chemical scaffold. Research on its derivatives illustrates the intersection between botanical chemistry, medicinal chemistry, and modern drug-discovery research.
For B2B buyers, selecting an Oridonin supplier should involve more than comparing prices.
Check:
CAS number
Chemical name
Molecular formula
Molecular weight
HPLC profile
Ask how the 98% specification is determined and request the corresponding analytical documentation.
A current-batch COA is more useful than a generic specification sheet.
Understand whether the supplier:
Manufactures the material
Controls purification
Performs analytical testing
Maintains batch records
For research-grade ingredients, technical communication can be as important as price.
A reliable supplier should be able to answer questions about
Purity
HPLC
Solubility
Storage
Packaging
Lead time
Documentation
Before placing an order, buyers can use the following checklist.
Confirm CAS 28957-04-2
Confirm molecular formula C20H28O6
Confirm molecular weight
Confirm ≥98% HPLC specification
Request current-batch COA
Request HPLC chromatogram
Confirm identity-testing method
Review residual solvent information
Review heavy-metal information
Confirm packaging
Confirm storage conditions
Confirm sample availability
Confirm production lead time
Confirm technical documentation
Evaluate long-term supply capability
Oridonin is a naturally occurring ent-kaurane diterpenoid primarily associated with Isodon rubescens. Its CAS number is 28957-04-2.
The commonly recognized CAS number is 28957-04-2.
The molecular formula is C20H28O6.
The molecular weight is approximately 364.4 g/mol.
Oridonin is primarily associated with Isodon rubescens, a species in the Lamiaceae family. Rabdosia rubescens is a recognized synonym.
No. Dong Ling Cao or Isodon rubescens extract is a complex botanical preparation, while Oridonin is a purified individual compound.
It generally indicates that Oridonin constitutes at least approximately 98% of the material according to the stated analytical method, commonly HPLC. The analytical method should always be reviewed alongside the stated purity.
HPLC is commonly used for quantitative analysis and purity assessment. Additional techniques such as LC-MS or NMR can be used for identity characterization depending on the application.
Oridonin has limited aqueous solubility, which has been identified as an important technical challenge in pharmaceutical formulation research.
High-purity Oridonin is primarily relevant to scientific research, natural-product chemistry, analytical studies, pharmaceutical chemistry, and formulation-development research.
Research into Oridonin and Oridonin derivatives is ongoing, but a research-grade Oridonin ingredient should not be represented as an approved pharmaceutical merely because pharmacological studies have been published.
Isodon rubescens contains numerous diterpenoids. Oridonin is one specific compound with its own chemical identity, molecular formula, and analytical profile.
High-purity Oridonin can be relevant to analytical research, but suitability as a formal reference standard depends on the required certification, purity characterization, intended analytical method, and applicable standards.
HPLC provides a practical way to separate and quantify Oridonin and assess the chromatographic profile of a sample.
Typical documents may include COA, specification sheet, HPLC chromatogram, SDS/MSDS, and technical data. Additional documents depend on the customer's application and regulatory requirements.
Storage recommendations should follow the supplier's validated specification and stability information. In general, minimizing unnecessary exposure to heat, moisture, and light is a prudent approach for purified natural products.
Yes. Numerous research programs have investigated structural modification of Oridonin to explore changes in physicochemical and biological properties.
One major reason is to investigate whether structural modification can address limitations of the parent compound, including solubility and pharmacokinetic characteristics.
The most important items include identity, HPLC purity, chromatogram, COA, production source, analytical method, contaminants, storage conditions, and supplier consistency.
No. "98% Oridonin" describes a purified compound specification, whereas "98% Isodon rubescens extract" would describe a very different product concept and should not be assumed to have the same chemical composition.
For high-purity botanical compounds such as Oridonin, it is tempting to evaluate suppliers based solely on the number printed on the COA.
However, professional procurement requires a broader view.
A robust quality assessment should consider:
Identity
Is the material actually Oridonin?
Purity
Does the material meet the stated ≥98% specification?
Analytical Method
How was the purity determined?
Chromatographic Profile
Does the HPLC chromatogram demonstrate a clean and consistent profile?
Contaminant Control
Are residual solvents, heavy metals, moisture, and microbiological parameters appropriately controlled?
Batch Consistency
Can the supplier provide the same specification repeatedly?
Traceability
Can the material be traced to a defined manufacturing and testing process?
This approach is particularly important when Oridonin is used in research projects where reproducibility is more important than simply achieving the lowest purchase price.
The development of Oridonin reflects a broader trend in the botanical ingredient industry: the transition from complex traditional extracts toward well-characterized natural compounds.
Researchers and manufacturers increasingly require:
Defined molecular identity
Standardized purity
Reliable analytical data
Consistent batch quality
Transparent technical documentation
At the same time, advances in natural-product chemistry are creating new opportunities for studying botanical compounds as molecular scaffolds rather than simply as traditional herbal extracts.
Oridonin is a particularly useful example of this transition because research has expanded from simple isolation and characterization to molecular mechanisms, pharmacokinetics, structural modification, delivery technologies, and derivative development.
The purpose of this guide is not to promote Oridonin through unsupported efficacy claims.
Instead, CQHERB aims to provide researchers, manufacturers, and purchasing professionals with a practical technical reference for understanding:
What Oridonin is
Where it comes from
How it differs from botanical extracts
How high-purity material is evaluated
Why HPLC matters
What technical challenges researchers should consider
How to evaluate suppliers
For botanical ingredients, reliable information is an essential part of product quality.
Oridonin is a structurally distinctive ent-kaurane diterpenoid primarily associated with Isodon rubescens. With a molecular formula of C20H28O6 and CAS 28957-04-2, it has become one of the most extensively studied diterpenoids from this botanical source.
Modern research extends from natural-product isolation and structural characterization to molecular biology, pharmacokinetics, formulation science, and the development of Oridonin derivatives. At the same time, researchers continue to investigate challenges such as limited aqueous solubility and bioavailability.
For B2B buyers, the key consideration is that 98% Oridonin is a purified single compound rather than a conventional Isodon rubescens extract. Its quality should therefore be evaluated through a combination of purity, identity, HPLC profile, contaminant control, documentation, and batch consistency.
As scientific interest in standardized natural compounds continues to expand, Oridonin represents an important example of how traditional botanical resources can become well-characterized materials for modern natural-product and pharmaceutical research.
If you are sourcing high-purity Oridonin (98%) for research, analytical development, formulation studies, or long-term B2B supply, technical specifications should be evaluated according to your intended application.
CQHERB can provide product information and technical documentation for evaluation, including:
COA
Product Specification
HPLC Chromatogram
SDS/MSDS
Technical Data
Sample Support
Packaging Information
Request Technical Information
PubChem. Oridonin – CID 5321010. National Center for Biotechnology Information.
Royal Botanic Gardens, Kew. Plants of the World Online: Isodon rubescens (Hemsl.) H.Hara.
Royal Botanic Gardens, Kew. Rabdosia rubescens (Hemsl.) H.Hara – synonym of Isodon rubescens.
Ali MA, et al. Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy – A comprehensive review. Food Science & Nutrition. 2024.
Zhang Y, Wang S, Dai M, et al. Solubility and Bioavailability Enhancement of Oridonin: A Review. Molecules. 2020;25(2):332.
Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity. PubMed-indexed review.
Sobral PJM, Vicente ATS, Salvador JAR. Recent advances in oridonin derivatives with anticancer activity. Frontiers in Chemistry. 2023.
The Natural Product Oridonin as an Anticancer Agent: Current Achievements and Problems. PubMed-indexed review. 2023.
Isolation and Purification of Oridonin from the Whole Plant of Isodon rubescens by High-Speed Counter-Current Chromatography.
Simultaneous characterization and quantification of 17 main compounds in Rabdosia rubescens by high performance liquid chromatography. PubMed.
Recent Advances on the Molecular Mechanisms of Apoptosis Induced by Natural Product Oridonin and Its Derivatives. 2026 review.
Anticancer mechanisms on pyroptosis induced by Oridonin: New potential targeted therapeutic strategies. Biomedicine & Pharmacotherapy. 2023.
The bioavailability enhancement and insight into the action mechanism of poorly soluble natural compounds from co-crystals preparation: Oridonin as an example. Phytomedicine. 2024.
Discovery and development of natural product oridonin-inspired anticancer agents. PubMed-indexed review.
Research progress and molecular mechanism of oridonin in the treatment of malignant melanoma. 2025 review.
Content Type: Ultimate Guide / Pillar Page
Knowledge Base Category: Botanical Extract Knowledge Base
Primary Search Intent: Informational + Commercial Investigation
Target Audience: Researchers, formulators, manufacturers, procurement professionals and ingredient buyers
Recommended Content Cluster:
Oridonin Ultimate Guide
↓
What Is Oridonin?
↓
Oridonin Chemical Structure
↓
Oridonin Solubility & Stability
↓
Oridonin HPLC & COA Guide
↓
Oridonin Extraction & Purification
↓
Oridonin vs. Isodon rubescens Extract
↓
How to Choose an Oridonin Supplier
↓
Oridonin FAQ Hub
This article intentionally distinguishes scientific research findings from established clinical or commercial claims. Oridonin has been extensively investigated in experimental systems, but published preclinical findings should not be presented as proof of human therapeutic efficacy. This positioning helps maintain the professional, research-oriented character of the CQHERB Knowledge Base and reduces unnecessary regulatory and advertising risk.